Korean J Blood Transfus.  1999 Dec;10(2):173-179.

Performance Evaluation of 'Dong-A Syphilis' EIA kit

Affiliations
  • 1Department of Clinical Pathology, University of Ulsan College of Medicine and Asan Medical Center.
  • 2Institute of Allergy and Clinical Immunology, Medical Research Center, Seoul National University Hospital.
  • 3Blood Transfusion Research Institute, Korean National Red Cross.
  • 4Dong-A Research Laboratory, Dong-A Pharmaceutical Co., Seoul, Korea.

Abstract

BACKGROUND
'Dong-A Syphilis' enzyme immunoassay(EIA) kit for detecting antibodies against T. pallidum was recently introduced. The performance of 'Dong-A Syphilis' in precision, sensitivity and specificity was evaluated to know the adequacy in substituting for VDRL as a primary screening test.
METHODS
Intra and inter-run precision were evaluated by positive and negative controls and 4 other concentrations which were made by mixing positive controls with negative controls. Sensitivity and specificity were evaluated using 120 samples positive in both VDRL and FTA-ABS and using 487 samples negative in VDRL, respectively. Positive rates of EIA and VDRL among 342 persons who visited health promotion center in Asan Medical Center were compared. RESLUTS: Intra-run precision was between 2.2% and 5.5%, and inter-run precision between 9.9% and 15.6%. Sensitivity and specificity were 99.2% and 99.7%, respectively. EIA showed higher positive rate (5.8%) than VDRL (3.5%). 11 samples (3.2%) were reactive only in both EIA and FTA-ABS.
CONCLUSION
The performance of 'Dong-A syphilis' EIA was so good in precision, sensitivity and specificty that the EIA kit could substitute for VDRL as a primary screening test for syphilis. EIA screening for syphilis would be more appropriate for a person to promote his own health in that it could detect untreated past infection.

Keyword

Syphilis; Enzyme immunoassay; Dong-A Syphilis

MeSH Terms

Antibodies
Chungcheongnam-do
Health Promotion
Humans
Immunoenzyme Techniques
Mass Screening
Sensitivity and Specificity
Syphilis
Antibodies
Full Text Links
  • KJBT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr